deeptek.ai

What It Is

DeepTek is an AI radiology company from India, positioned around making high-quality diagnostics more affordable and accessible through AI-powered radiology solutions. The site highlights product lines including Augmento Enterprise, Chest Xray AI, Genki lung health screening tool, AI Driven Diagnostic Reporting, Teleradiology, and Agentic AI Powered Reporting, covering screening, image reading, reporting, and collaborative workflows.

Core Capabilities

Based on the captured content, DeepTek’s core focus is chest X-rays and lung health, especially public-health tuberculosis screening and clinical chest X-ray reporting. Augmento Enterprise is described as an AI Deployment Platform that includes advanced CT/MR/PET-CT viewers, comprehensive analytics, and a collaboration platform; Genki is more oriented toward end-to-end lung health screening. The product portfolio appears well suited for healthcare institutions looking to embed AI into radiology workflows, but the page does not disclose key metrics such as model architecture, training data, accuracy, sensitivity/specificity, or regulatory approvals. More information would be needed to assess clinical reliability.

Pricing and Integration

The main content does not provide public pricing, plans, free quotas, or trial policies. It only offers a Request A Demo entry point, suggesting that DeepTek is more likely sold through enterprise sales or project-based deployments. On the integration side, the page mentions an AI Deployment Platform, RIS-VIM, Gateway Mobile App, and collaboration platform, but does not clearly specify API documentation, PACS/RIS/HIS integration capabilities, deployment models, or localization support. Technical interfaces and implementation costs should be confirmed before procurement.

Pros and Cons

The main strength is its clear vertical focus: DeepTek specializes in radiology AI and covers public-health screening, clinical reporting, teleradiology, and advanced image viewing, making the use cases relatively complete. It also provides access to research publications, white papers, and regulatory resources, which helps with further due diligence. The limitation is that the publicly available information is not very transparent: pricing, data privacy, Chinese-language support, compliance certifications, and quantified model performance are not shown in the captured text. As with any medical AI, outputs must still be reviewed by physicians and implemented in line with local regulations and hospital workflows.

Who It’s For and Access from China

DeepTek is better suited for hospital radiology departments, third-party imaging centers, public-health screening programs, and teleradiology providers to evaluate. Access from China is unknown, and payment methods are not disclosed. For deployment in China, key points to verify include network accessibility, cross-border data and local regulatory requirements, Chinese reporting capabilities, and local alternatives.